International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working Group

Published on Dec 1, 2019in Arthritis Care and Research4.056
· DOI :10.1002/ACR.23799
Martijn A. H. Oude Voshaar12
Estimated H-index: 12
(UT: University of Twente),
Zofia Das Gupta1
Estimated H-index: 1
+ 26 AuthorsHarald E. Vonkeman25
Estimated H-index: 25
(UT: University of Twente)
Sources
Abstract
Background The implementation of value based healthcare (VBHC) in inflammatory arthritis (IA) requires a standardized set of modifiable outcomes and risk‐adjustment variables that is feasible to implement worldwide. Methods The International Consortium for Health Outcomes Measurement (ICHOM) assembled a multidisciplinary working group, consisting of 24 experts from six continents, including six patient representatives, to develop a Standard Set of outcomes for IA. The process followed a structured approach using a modified Delphi process to reach consensus on 1) conditions covered by the set, 2) outcome domains, 3) outcome measures, 4) risk‐adjustment variables. Consensus on decision areas two to four were supported by systematic literature reviews and consultation of experts. Results The ICHOM IA Standard Set covers patients with rheumatoid arthritis (RA), axial spondyloarthritis, psoriatic arthritis and juvenile idiopathic arthritis (JIA). We recommend that the following outcomes be collected at least annually: pain, fatigue, activity limitations, overall physical and mental health impact, work/school/housework ability and productivity, disease activity, and serious adverse events. Validated measures for patient‐reported outcomes were endorsed, and linked to common reporting metrics. Age, sex at birth, educational level, smoking status, comorbidities, time since diagnosis, and rheumatoid factor and anti‐citrullinated protein antibody lab testing for RA and JIA should be collected as risk‐adjustment variables. Conclusion We present the ICHOM IA Standard Set of outcomes that enables healthcare providers to implement the value based healthcare framework and enable comparison of outcomes important to patients with IA.
Download
📖 Papers frequently viewed together
36 Citations
References43
Newest
#1Wouter R. VerberneH-Index: 3
#2Zofia Das-GuptaH-Index: 3
Last. Willem Jan W Bos (LUMC: Leiden University Medical Center)H-Index: 9
view all 20 authors...
Value-based health care is increasingly promoted as a strategy for improving care quality by benchmarking outcomes that matter to patients relative to the cost of obtaining those outcomes. To support the shift toward value-based health care in chronic kidney disease (CKD), the International Consortium for Health Outcomes Measurement (ICHOM) assembled an international working group of health professionals and patient representatives to develop a standardized minimum set of patient-centered outcom...
41 CitationsSource
#1M.A.H. Oude Voshaar (UT: University of Twente)H-Index: 4
#2Harald E. Vonkeman (UT: University of Twente)H-Index: 25
Last. M.A.F.J. van de Laar (UT: University of Twente)H-Index: 29
view all 12 authors...
Objectives Outcomes obtained using different physical function patient reported outcome measures (PROMs) are difficult to compare. To facilitate standardization of physical function outcome measurement and reporting we developed an item response theory (IRT) based standardized physical function score metric for ten commonly used physical function PROMs.
5 CitationsSource
#1Andrew H Kim (John Radcliffe Hospital)H-Index: 1
#2Charlotte RobertsH-Index: 6
Last. Simon Travis (John Radcliffe Hospital)H-Index: 87
view all 25 authors...
Background and Aims: Success in delivering value-based healthcare involves measuring outcomes that matter most to patients. Our aim was to develop a minimum Standard Set of patient-centred outcome measures for inflammatory bowel disease [IBD], for use in different healthcare settings. Methods: An international working group [n = 25] representing patients, patient associations, gastroenterologists, surgeons, specialist nurses, IBD registries and patient-reported outcome measure [PROM] methodologi...
52 CitationsSource
#1Asangaedem Akpan (Aintree University Hospitals NHS Foundation Trust)H-Index: 5
#1Asangaedem AkpanH-Index: 1
Last. Jay Banerjee (University Hospitals of Leicester NHS Trust)H-Index: 12
view all 31 authors...
Background: The International Consortium for Health Outcomes Measurement (ICHOM) was founded in 2012 to propose consensus-based measurement tools and documentation for different conditions and populations.This article describes how the ICHOM Older Person Working Group followed a consensus-driven modified Delphi technique to develop multiple global outcome measures in older persons. The standard set of outcome measures developed by this group will support the ability of healthcare systems to impr...
62 CitationsSource
#1Caroline Foust-Wright (Harvard University)H-Index: 3
#2Stephanie C. WissigH-Index: 10
Last. Ian Milsom (Sahlgrenska University Hospital)H-Index: 74
view all 19 authors...
Introduction and hypothesis Standardized measures enable the comparison of outcomes across providers and treatments giving valuable information for improving care quality and efficacy. The aim of this project was to define a minimum standard set of outcome measures and case-mix factors for evaluating the care of patients with overactive bladder (OAB).
12 CitationsSource
#1Alexander C. Allori (Duke University)H-Index: 19
#2Thomas KelleyH-Index: 1
Last. Karen W. Wong (U of T: University of Toronto)H-Index: 1
view all 28 authors...
Care of the patient with cleft lip and/or palate remains complex. Prior attempts at aggregating data to study the effectiveness of specific interventions or overall treatment protocols have been hindered by a lack of data standards. There exists a critical need to better define the outcomes—particularly those that matter most to patients and their families—and to standardize the methods by which these outcomes will be measured. This report summarizes the recommendations of an international, mult...
59 CitationsSource
#1Alexander Obbarius (Humboldt University of Berlin)H-Index: 6
Last. Matthias Rose (UMass: University of Massachusetts Amherst)H-Index: 49
view all 24 authors...
Purpose National initiatives, such as the UK Improving Access to Psychological Therapies program (IAPT), demonstrate the feasibility of conducting empirical mental health assessments on a large scale, and similar initiatives exist in other countries. However, there is a lack of international consensus on which outcome domains are most salient to monitor treatment progress and how they should be measured. The aim of this project was to propose (1) an essential set of outcome domains relevant acro...
36 CitationsSource
#1Wee Loon Ong (Monash University)H-Index: 7
#2M SchouwenburgH-Index: 6
Last. Christobel Saunders (UWA: University of Western Australia)H-Index: 47
view all 28 authors...
A major challenge in value-based health care is the lack of standardized health outcomes measurements, hindering optimal monitoring and comparison of the quality of health care across different settings globally. The International Consortium for Health Outcomes Measurement (ICHOM) assembled a multidisciplinary international working group, comprised of 26 health care providers and patient advocates, to develop a standard set of value-based patient-centered outcomes for breast cancer (BC). The wor...
94 CitationsSource
#1Jessica A. Zerillo (Harvard University)H-Index: 8
#2Maartje Gisele Schouwenburg (LUMC: Leiden University Medical Center)H-Index: 2
Last. Rob A. E. M. Tollenaar (LUMC: Leiden University Medical Center)H-Index: 71
view all 29 authors...
Importance Global health systems are shifting toward value-based care in an effort to drive better outcomes in the setting of rising health care costs. This shift requires a common definition of value, starting with the outcomes that matter most to patients. Objective The International Consortium for Health Outcomes Measurement (ICHOM), a nonprofit initiative, was formed to define standard sets of outcomes by medical condition. In this article, we report the efforts of ICHOM’s working group in c...
46 CitationsSource
#1Ana Maria Orbai (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 22
#2Maarten de Wit (VU: VU University Amsterdam)H-Index: 34
Last. Alexis Ogdie (UPenn: University of Pennsylvania)H-Index: 39
view all 27 authors...
Objective To identify a core set of domains (outcomes) to be measured in psoriatic arthritis (PsA) clinical trials that represent both patients9 and physicians9 priorities. Methods We conducted (1) a systematic literature review (SLR) of domains assessed in PsA; (2) international focus groups to identify domains important to people with PsA; (3) two international surveys with patients and physicians to prioritise domains; (4) an international face-to-face meeting with patients and physicians usi...
122 CitationsSource
Cited By20
Newest
Source
Purpose null To describe the principles, process, and results of creating the International Consortium for Health Outcomes Measurement (ICHOM) standard set for hand and wrist conditions. null null null Methods null Following the standardized methods of ICHOM, an international working group of hand surgeons, therapists, and researchers was assembled to develop an evidence-based, patient-centered, standard set of outcome measures for patients with hand and wrist conditions. Multiple systematic rev...
Source
#1Arun Bhaskar (Imperial College Healthcare)H-Index: 4
#2Alan Bell (U of T: University of Toronto)H-Index: 15
Last. Eva FrohlichH-Index: 1
view all 23 authors...
BACKGROUND Globally, medical cannabis legalization has increased in recent years and medical cannabis is commonly used to treat chronic pain. However, there are few randomized control trials studying medical cannabis indicating expert guidance on how to dose and administer medical cannabis safely and effectively is needed. METHODS Using a multistage modified Delphi process, twenty global experts across nine countries developed consensus-based recommendations on how to dose and administer medical...
3 CitationsSource
#1Jean-Guillaume Letarouilly (university of lille)H-Index: 2
#2René-Marc Flipo (university of lille)H-Index: 12
Last. Julien PaccouH-Index: 20
view all 5 authors...
There is growing interest in the alterations in body composition (BC) that accompany rheumatoid arthritis (RA). The purpose of this review is to (i) investigate how BC is currently measured in RA patients, (ii) describe alterations in body composition in RA patients and (iii) evaluate the effect on nutrition, physical training, and treatments; that is, corticosteroids and biologic Disease Modifying Anti-Rheumatic Disease (bDMARDs), on BC in RA patients. The primary-source literature for this rev...
Source
Last. Mike J. Crawford (Imperial College London)H-Index: 58
view all 21 authors...
PURPOSE The purpose of the article is to present standard set of outcomes for people with personality disorder (PD), in order to facilitate patient outcome measurement worldwide. METHODS The International Consortium for Health Outcomes Measurement (ICHOM) gathered a multidisciplinary international working group, consisting of 16 experts, including clinicians, nurses, psychologists, methodologists and patient representatives, to develop a standard set of outcome measures for people with PD. The D...
Source
Introduction: Chronic rhinosinusitis (CRS) is often classified primarily on the basis of the absence or presence of nasal polyps (NPs), that is, as CRS with nasal polyps (CRSwNP) or CRS without nasal polyps (CRSsNP). Additionally, according to the percentage of eosinophils, CRSwNP can be further divided into eosinophilic CRSwNP (ECRSwNP) and non-ECRSwNP. CRSwNP is a significant public health problem with a considerable socioeconomic burden. Previous research reported that the pathophysiology of ...
Source
Last. Carin A. Uyl-de Groot (EUR: Erasmus University Rotterdam)H-Index: 24
view all 3 authors...
Abstract Objectives This article aims to explore overlaps and differences between the emerging concept of value-based healthcare (VBHC) and the established field of cost-effectiveness analysis (CEA), as well as the feasibility of integrating them together. Interest in VBHC has grown significantly in developed countries that seek to preserve the sustainability of their healthcare systems. Consequently, it is likely that VBHC will soon play a meaningful role in health economic policy and decision ...
Source
#1Ellen Dalen Arnstad (NTNU: Norwegian University of Science and Technology)H-Index: 4
#1Arnstad Ed (Nord-Trøndelag Hospital Trust)
Last. Marite Rygg (NTNU: Norwegian University of Science and Technology)H-Index: 21
view all 13 authors...
BACKGROUND To study fatigue in young adults with juvenile idiopathic arthritis (JIA) 18 years after disease onset, and to compare with controls. METHODS Consecutive children with onset of JIA between 1997 and 2000, from geographically defined areas of Norway, Sweden, Denmark and Finland were followed for 18 years in a close to population-based prospective cohort study. Clinical features, demographic and patient-reported data were collected. Inclusion criteria in the present study were a baseline...
Source
#1W. Benjamin NowellH-Index: 10
#2K. GaviganH-Index: 7
Last. Jeffrey R. Curtis (UAB: University of Alabama at Birmingham)H-Index: 91
view all 9 authors...
BACKGROUND Patient-reported outcomes (PROs) are increasingly used to track symptoms and to assess disease activity, quality of life, and treatment effectiveness. It is therefore important to understand which PROs patients with rheumatic and musculoskeletal disease consider most important to track for disease management. METHODS Adult US patients within the ArthritisPower registry with ankylosing spondylitis, fibromyalgia syndrome, osteoarthritis, osteoporosis, psoriatic arthritis, rheumatoid art...
2 CitationsSource
#1Sabrina Mai Nielsen (UCPH: University of Copenhagen)H-Index: 13
#2Marianne Uggen Rasmussen (UCPH: University of Copenhagen)H-Index: 3
Last. Robin Christensen (UCPH: University of Copenhagen)H-Index: 74
view all 21 authors...
Objectives The Outcome Measures in Rheumatology Initiative established the Contextual Factors Working Group to guide the understanding, identification and handling of contextual factors for clinical trials. In clinical research, different uses of the term ‘contextual factors’ exist. This study explores the perspectives of researchers (including clinicians) and patients in defining 9contextual factor’ and its related terminology, identifying such factors and accounting for them in trials across r...
1 CitationsSource